Mesoblast has entered into an Agreement with Celgene Read the full story
Mesoblast has entered into an Agreement with Celgene Read the full story
Natera has raised approximately $55.5 million in funding led by Silicon Valley life sciences investment firm Sofinnova Ventures Read the full story
Nabriva Therapeutics announced the successful completion of a $120 million Series B financing Read the full story
True North Therapeutics has completed a $35 million Series B equity financing Read the full story
ImmunoGen announced a $200 million non-dilutive royalty transaction with funds managed by TPG Special Situations Partners Read the full story
Novan Therapeutics has secured $50 million in an oversubscribed private financing Read the full story
Aeglea Biotherapeutics announced the closing of a $44 million Series B financing Read the full story
Kura Oncology has entered into an agreement with Janssen Pharmaceutica for an exclusive license to develop and commercialize tipifarnib in the field of oncology Read the full story
PhaseBio Pharmaceuticals has closed a $40 million Series C financing round led by AstraZeneca. Read the full story
Collegium Pharmaceutical has raised a $50 million financing Read the full story